Influence of excessive body weight on cancer development and prognosis

• Autorzy: Alicja Bielak , Jakub Gryta , Karolina Iwan , Martyna Janczewska , Maria Kalicka , Tomasz Krysa , Agata Kolasa , Zuzanna Radziejowska , Magdalena Szklarz , Jan Kutermankiewicz
• Języki publikacji: EN

Abstrakty

EN

Introduction and purpose According to the WHO, overweight and obesity are defined as excessive or abnormal accumulation of adipose tissue, leading to deterioration of health. Excessive body weight is a constantly growing public health problem that has reached the scale of a pandemic. Currently, there is ample evidence that excess body weight increases the risk of developing cancer and worsens the prognosis. The aim of this review is to analyze the impact of overweight and obesity on cancer development and prognosis, and to elucidate pathogenesis. State of knowledge Based on the current state of knowledge in epidemiology, it is estimated that approximately 20% of all malignancies are related to excessive body weight. So far, there is sufficient evidence to support an association between excess body fat and 13 out of 24 cancer sites: esophagus, gastric cardia, colon, liver, gallbladder, pancreas, postmenopausal breast, endometrium, ovary, kidney, meningioma, thyroid and multiple myeloma. Adipose tissue cells produce growth factors, hormones and cytokines that can interfere with the regulation of cell growth and survival. Excess adipose tissue leads to systemic chronic inflammation, oxidative stress, insulin resistance, hyperinsulinemia, increase in sex hormones, increase in leptin levels and a decrease in adiponectin levels. This leads to DNA defects, stimulation of angiogenesis, cell proliferation and inhibition of apoptosis, and thus promotes the development of cancer. In addition, studies have estimated that excess body weight is responsible for 14% of cancer deaths in men and 20% in women. Conclusions Due to the increasing problem of obesity and cancer worldwide and the proven causal relationship between these diseases, it is necessary to intensify nutrition education and promote a healthy lifestyle in order to minimize excessive body weight, and thus reduce the incidence of cancer.(original abstract)

Słowa kluczowe

EN

Sport; Illness; Health; Quality of life

PL

Sport; Choroby; Zdrowie; Jakość życia

• Czasopismo: Quality in Sport
• Rocznik: 2023
• Tom: 9
• Numer: nr 1
• Strony: 88--93

Twórcy

autor

Alicja Bielak

• 1 Wojskowy Szpital Kliniczny z Polikliniką SPZOZ w Lublinie

autor

Jakub Gryta

• 1 Wojskowy Szpital Kliniczny z Polikliniką SPZOZ w Lublinie

autor

Karolina Iwan

• 1 Wojskowy Szpital Kliniczny z Polikliniką SPZOZ w Lublinie

autor

Martyna Janczewska

• Samodzielny Publiczny Szpital Kliniczny Nr 4 w Lublinie

autor

Maria Kalicka

• 1 Wojskowy Szpital Kliniczny z Polikliniką SPZOZ w Lublinie

autor

Tomasz Krysa

• Wojewódzki Szpital Specjalistyczny im. Stefana Kardynała Wyszyńskiego SPZOZ w Lublinie

autor

Agata Kolasa

• 1 Wojskowy Szpital Kliniczny z Polikliniką SPZOZ w Lublinie

autor

Zuzanna Radziejowska

• 1 Wojskowy Szpital Kliniczny z Polikliniką SPZOZ w Lublinie

autor

Magdalena Szklarz

• 1 Wojskowy Szpital Kliniczny z Polikliniką SPZOZ w Lublinie

autor

Jan Kutermankiewicz

• Samodzielny Publiczny Szpital Kliniczny nr 1 in Lublin

Bibliografia

• World Health Organization. Obesity and overweight [Internet]. Geneva: WHO; 2020 Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492.
• Arnold M, Pandeya N, Byrnes G, Renehan PAG, Stevens GA, Ezzati PM, Ferlay J, Miranda JJ, Romieu I, Dikshit R, Forman D, Soerjomataram I. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 2015 Jan;16(1):36-46. doi: 10.1016/S1470-2045(14)71123-4.
• Ligibel JA, Alfano CM, Courneya KS, Demark-Wahnefried W, Burger RA, Chlebowski RT, Fabian CJ, Gucalp A, Hershman DL, Hudson MM, Jones LW, Kakarala M, Ness KK, Merrill JK, Wollins DS, Hudis CA. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol. 2014 Nov 1;32(31):3568-74. doi:10.1200/JCO.2014.58.4680.
• Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003 Apr 24;348(17):1625-38. doi: 10.1056/NEJMoa021423.
• Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K; International Agency for Research on Cancer Handbook Working Group. Body Fatness and Cancer--Viewpoint of the IARC Working Group. N Engl J Med. 2016 Aug 25;375(8):794-8. doi: 10.1056/NEJMsr1606602.
• Berger NA. Young Adult Cancer: Influence of the Obesity Pandemic. Obesity (Silver Spring). 2018 Apr;26(4):641-650. doi: 10.1002/oby.22137.
• Maciejewska-Cebulak M. : Wpływ nadwagi i otyłości na powstawanie nowotworów. Forum Medycyny Rodzinnej 2017;11(2):73-79.
• Iyengar NM, Gucalp A, Dannenberg AJ, Hudis CA. Obesity and Cancer Mechanisms: Tumor Microenvironment and Inflammation. J Clin Oncol. 2016 Dec 10;34(35):4270-4276. doi: 10.1200/JCO.2016.67.4283.
• Goday A, Barneto I, García-Almeida JM, Blasco A, Lecube A, Grávalos C, Martínez de Icaya P, de las Peñas R, Monereo S, Vázquez L, Palacio JE, Pérez-Segura P. Obesity as a risk factor in cancer: A national consensus of the Spanish Society for the Study of Obesity and the Spanish Society of Medical Oncology. Clin Transl Oncol. 2015 Oct;17(10):763-71. doi: 10.1007/s12094-015-1306-y.
• M. L. Slattery, K. Curtin, E. M. Poole et al., "Genetic variation in C-reactive protein in relation to colon and rectal cancer risk and survival," International Journal of Cancer, vol. 128, no. 11, pp. 2726-2734, 2011. doi: 10.1002/ijc.25721
• Krupa-Kotara K, Dakowska D. Impact of obesity on risk of cancer. Cent Eur J Public Health. 2021;29(1):38-44. doi: 10.21101/cejph.a5913.
• Kompella P, Vasquez KM. Obesity and cancer: A mechanistic overview of metabolic changes in obesity that impact genetic instability. Mol Carcinog. 2019 Sep;58(9):1531-1550. doi: 10.1002/mc.23048.
• Deng T, Lyon CJ, Bergin S, Caligiuri MA, Hsueh WA. Obesity, Inflammation, and Cancer. Annu Rev Pathol. 2016 May 23;11:421-49. doi: 10.1146/annurev-pathol-012615-044359.
• Kruk J. Lifestyle components and primary breast cancer prevention. Asian Pac J Cancer Prev. 2014;15(24):10543-55. doi: 10.7314/apjcp.2014.15.24.10543.
• Cohen DH, LeRoith D. Obesity, type 2 diabetes, and cancer: the insulin and IGF connection. Endocr Relat Cancer. 2012 Sep 5;19(5):F27-45. doi: 10.1530/ERC-11-0374.
• De Pergola G, Silvestris F. Obesity as a major risk factor for cancer. J Obes. 2013;2013:291546. doi: 10.1155/2013/291546.
• Frasca F, Pandini G, Sciacca L, Pezzino V, Squatrito S, Belfiore A, Vigneri R. The role of insulin receptors and IGF-I receptors in cancer and other diseases. Arch Physiol Biochem. 2008 Feb;114(1):23-37. doi: 10.1080/13813450801969715.
• Wueest S, Seelig E, Timper K, Lyngbaek MP, Karstoft K, Donath MY, Ellingsgaard H, Konrad D. IL-6 Receptor Blockade Increases Circulating Adiponectin Levels in People with Obesity: An Explanatory Analysis. Metabolites. 2021 Jan 29;11(2):79. doi: 10.3390/metabo11020079.
• Vansaun MN. Molecular pathways: adiponectin and leptin signaling in cancer. Clin Cancer Res. 2013 Apr 15;19(8):1926-32. doi: 10.1158/1078-0432.CCR-12-0930.
• Lin TC, Hsiao M. Leptin and Cancer: Updated Functional Roles in Carcinogenesis, Therapeutic Niches, and Developments. Int J Mol Sci. 2021 Mar 11;22(6):2870. doi: 10.3390/ijms22062870.
• Buonaiuto R, Napolitano F, Parola S, De Placido P, Forestieri V, Pecoraro G, Servetto A, Formisano L, Formisano P, Giuliano M, Arpino G, De Placido S, De Angelis C. Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer. Biomolecules. 2022 Sep 29;12(10):1394. doi: 10.3390/biom12101394.
• Gong TT, Wu QJ, Wang YL, Ma XX. Circulating adiponectin, leptin and adiponectin-leptin ratio and endometrial cancer risk: Evidence from a meta-analysis of epidemiologic studies. Int J Cancer. 2015 Oct 15;137(8):1967-78. doi: 10.1002/ijc.29561.
• Arnold M, Pandeya N, Byrnes G, Renehan PAG, Stevens GA, Ezzati PM, Ferlay J, Miranda JJ, Romieu I, Dikshit R, Forman D, Soerjomataram I. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 2015 Jan;16(1):36-46. doi: 10.1016/S1470-2045(14)71123-4.
• Arnold M, Touillaud M, Dossus L, Freisling H, Bray F, Margaritis I, Deschamps V, Soerjomataram I. Cancers in France in 2015 attributable to high body mass index. Cancer Epidemiol. 2018 Feb;52:15-19. doi: 10.1016/j.canep.2017.11.006.
• Larsson SC, Wolk A. Body mass index and risk of non-Hodgkin's and Hodgkin's lymphoma: a meta-analysis of prospective studies. Eur J Cancer. 2011 Nov;47(16):2422-30. doi: 10.1016/j.ejca.2011.06.029.
• Zakaria D, Shaw A. Cancers attributable to excess body weight in Canada in 2010. Health Promot Chronic Dis Prev Can. 2017 Jul;37(7):205-214. doi: 10.24095/hpcdp.37.7.01.
• Islami F, Goding Sauer A, Gapstur SM, Jemal A. Proportion of Cancer Cases Attributable to Excess Body Weight by US State, 2011-2015. JAMA Oncol. 2019 Mar 1;5(3):384-392. doi: 10.1001/jamaoncol.2018.5639.
• Wolin KY, Carson K, Colditz GA. Obesity and cancer. Oncologist. 2010;15(6):556-65. doi: 10.1634/theoncologist.2009-0285.
• Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003 Apr 24;348(17):1625-38. doi: 10.1056/NEJMoa021423.
• Adams TD, Stroup AM, Gress RE, Adams KF, Calle EE, Smith SC, Halverson RC, Simper SC, Hopkins PN, Hunt SC. Cancer incidence and mortality after gastric bypass surgery. Obesity (Silver Spring). 2009 Apr;17(4):796-802. doi: 10.1038/oby.2008.610.
• Nuotio J, Laitinen TT, Sinaiko AR, Woo JG, Urbina EM, Jacobs DR Jr, Steinberger J, Prineas RJ, Sabin MA, Burgner DP, Minn H, Burns TL, Bazzano LA, Venn AJ, Viikari JSA, Hutri-Kähönen N, Daniels SR, Raitakari OT, Magnussen CG, Juonala M, Dwyer T. Obesity during childhood is associated with higher cancer mortality rate during adulthood: the i3C Consortium. Int J Obes (Lond). 2022 Feb;46(2):393-399. doi: 10.1038/s41366-021-01000-3.

Identyfikatory

DOI

10.12775/QS.2023.09.01.012